Longaeva Partners’s Caris Life Sciences, Inc. Common Stock CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39M Buy
+1,459,745
New +$39M 7.96% 1